Biology Reference
In-Depth Information
[53] Murphy WJ, Welniak LA, Taub DD, Wiltrout RH, Taylor PA, Vallera DA, et al. Differ-
ential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-
host disease after allogeneic bone marrow transplantation in mice. J Clin Invest
1998;102:1742-8.
[54] Yang YG, Dey BR, Sergio JJ, Pearson DA, Sykes M. Donor-derived interferon gamma is
required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest
1998;102:2126-35.
[55] Burman AC, Banovic T, Kuns RD, Clouston AD, Stanley AC, Morris ES, et al. IFN gamma
differentially controls the development of idiopathic pneumonia syndrome and GVHD
of the gastrointestinal tract. Blood 2007;110:1064-72.
[56] Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I, et al. Absence of donor Th17 leads to
augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood
2008;112:2101-10.
[57] Mauermann N, Burian J, von Garnier C, Dirnhofer S, Germano D, Schuett C, et al.
Interferon-γ regulates idiopathic pneumonia syndrome, a TH17 + CD4 + T cell-mediated
graft versus host disease. Am J Respir Crit Care Med 2008;178:379-88.
[58] Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, et al. IL-17 contributes
to CD4-mediated graft-versus-host disease. Blood 2009;113:945-52.
[59] Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS. In vitro-
differentiated T H 17 cells mediate lethal acute graft-versus-host disease with severe
cutaneous and pulmonary pathologic manifestations. Blood 2009;113:1365-74.
[60] Iclozan C, Yu Y, Liu C, Liang Y, Yi T, Anasetti C, et al. T helper17 cells are sufficient but
not necessary to induce acute graft-versus-host disease. Biol Blood Marrow Transplant
2010;16:170-8.
[61] Das R, Chen X, Komorowski R, Hessner MJ, Drobyski WR. Interleukin 23 secretion by
donor antigen presenting cells is critical for organ-specific pathology in graft versus
host disease. Blood 2009;113:2352-62.
[62] Yi T, Chen Y, Wang L, Du G, Huang D, Zhao D, et al. Reciprocal differentiation and
tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
Blood 2009;114:3101-12.
[63] Higman MA, Vogelsang GB. Chronic graft versus host disease. Br J Haematol
2004;25:435-54.
[64] Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmunity after al-
logeneic bone marrow transplantation: a study of 53 long-term-surviving patients.
Transplantation 1988;46:238-40.
[65] Rouquette-Gally AM, Boyeldieu D, Gluckman E, Abuaf N, Combrisson A. Autoimmunity
in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren's
syndrome and scleroderma. Br J Haematol 1987;66:45-7.
[66] Sherer Y, Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow
transplantation. Bone Marrow Transplant 1998;22:873-81.
[67] Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health Consensus
Development Project on criteria for clinical trials in chronic graft versus host dis-
ease. I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant
2005;11:945-55.
[68] Tivol EA, Komorowski R, Drobyski WR. Emergent autoimmunity in graft versus host dis-
ease. Blood 2005;105:4887-93.
[69] Chen X, Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR.
Absence of regulatory T-cell control of T H 1 and T H 17 cells is responsible for the
autoimmune-mediated pathology in chronic graft-versus-host disease. Blood
2007;110:3804-13.
[70] Axtell RC, Xu L, Barnum SR, Raman C. CD5-CK2 binding/activation-deficient mice are
resistant to experimental autoimmune encephalomyelitis: protection is associated with
diminished populations of IL-17 expressing T cells in the central nervous system. J Im-
munol 2006;177:8542-9.
[71] Chen X, Das R, Komorowski R, van Snick J, Uyttenhove C, Drobyski WR. Interleukin 17
is not required for autoimmune-mediated pathologic damage during chronic graft-
versus-host disease. Biol Blood Marrow Transplant 2010;16:123-8.
[72] Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, et al. Transplantation of
bone marrow as compared with peripheral-blood cells from HLA-identical relatives in
patients with hematologic cancers. N Engl J Med 2001;344:175-81.
[73] Hill GR, Olver SD, Kuns RD, Varelias A, Raffelt NC, Don AL, et al. Stem cell mobiliza-
tion with G-CSF induces type-17 differentiation and promotes scleroderma. Blood
2010;116:819-28.
[74] Nishimori H, Maeda Y, Teshima T, Sugiyama H, Kobayashi K, Yamasuji Y, et al. Synthetic
retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1
and Th17. Blood 2012;119:285-95.
294
Search WWH ::




Custom Search